Loring Wolcott & Coolidge Fiduciary Advisors LLP Haemonetics Corp Transaction History

Loring Wolcott & Coolidge Fiduciary Advisors LLP

$11.1 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 Apr 15, 2020	SELL	$74.34 - $121.82 $34,270 - $56,159	-461 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$117.16 - $138.52 $54,010 - $63,857	461 New	461 $58,000

Others Institutions Holding HAE

# of Institutions

332

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$450 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$390 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$335 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$317 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$304 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.87B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loring Wolcott & Coolidge Fiduciary Advisors LLP, based on Form 13F filings with the SEC.

News

Stay updated on Loring Wolcott & Coolidge Fiduciary Advisors LLP with notifications on news.

Account